Printer-friendly versionPrinter-friendly version

Elimination of Viral Hepatitis in Hungary: Lessons learnt and the way forward

Meeting objectives:

  • Provide an overview of the current viral hepatitis situation in Hungary: surveillance systems, epidemiology, screening, burden, prevention and the cascade of care
  • Discuss achievements and challenges in the prevention of viral hepatitis, the possible implementation of new prevention strategies in Hungary
  • Discuss the development, the implementation of a National hepatitis plan.
  • Assess the needs to achieve the goal of eliminating viral hepatitis as a major public health threat by 2030 as set out in the WHO Global Strategy and WHO Europe Action Plan, building on the UN Sustainable Development Goals’ (SDG) commitments.
  • Discuss successes, issues and barriers to overcome, and the way forward

Background document (Pdf, 6.730 kB)

Wednesday 30 October 2019

Session 1: Opening and objectives      

Chairs: Zsuzsa Schaff – Johannes Hallauer

09:00 - 09:30    

Session 2:  The health care system in Hungary

09:30 – 10:00    Introduction in the health care system of Hungary (Pdf, 1.670 kB), Dr.Péter Csányi  (deputy secretary of Health - EMMI)

10:00 - 10:20     Questions

Session 3:  Current viral hepatitis situation, Epidemiology, screening, burden of disease in Hungary

10:20 - 10:50     Hepatitis: surveillance and epidemiological situation, Epidemiology of hepatitis in Hungary (Pdf, 1.051 kB), Dr.Cecilia Müller (head, NNK)

10:50 - 11:15     Coffee break

Chairs: Gabriella Pár – Rui Tato Marinho

11:15 - 11:40     Disease Burden in Hungary: chronic viral hepatitis and liver disease in Hungary (Pdf, 319 kB), Prof. Istvan Tornai

11:40 - 12:00     Overview of Hepatitis surveillance and  Epidemiology in Europe (Pdf, 984 kB), Erika Duffel, ECDC

12:00 - 12:10     Question and discussion

12:10 - 12:30     Treatment and follow up of HCV-related liver disease (Pdf, 177 kB) (Dr Mihály Makara) & Chronic HCV diagnostic methods in Hungary 1992-2019 (Pdf, 986 kB) (Dr Judit Gervain)

Dr.Mihály Makara, Dr.Gervain Judit

12:30 - 12:40     Questions

12:40 - 13:30     Lunch

Chairs: Ferenc Szalay – Vladimir Chulanov

13:30 – 13:50    Hepatitis in Risk groups in Hungary, Screening programmes among injecting drug users in Hungary. Maria Dudas - Horváth-Tarján Anna

14:00 – 14:15    Screening in emergency units (Pdf, 142 kB), Prof. Istvan Tornai

14:15 – 14:30    Screening by family doctors (Pdf, 932 kB), Prof. Ferenc Szalay

14:30 – 14:45    HCV screening in homosexual communities (Pdf, 210 kB), Dr. Eszter Újhelyi

14:45 - 15:00     Questions

15:00 - 15:20     Optimization of screening strategies for viral hepatitis (Pdf, 2.334 kB), John Ward (Coalition for Global Hepatitis Elimination The Task Force for Global Health )

15:20- 15:30      Question and discussion

15:30- 15:50      Coffee break

Session 4:  Prevention of viral hepatitis 

Chairs: Istaván Vályi-Nagy  - Vana Papaevangelou

15:50- 16:10      Vaccination programs in Hungary (Pdf, 429 kB), Dr. Zsuzsanna Molnár

16:10- 16:30      Hepatitis vaccination worldwide: Lessons learnt and the way forward (Pdf, 3.742 kB), Pierre Van Damme (Vaccine and Infectious Disease Institute, University, Antwerp, Belgium)

16:30- 16:40      Question and discussion

Session 5:  Control of viral hepatitis 

16:40- 17:00      Hepatitis case finding – Screening programmes and cascade of care  in Hungary - Hepatitis research in Hungary, from identification to treatment (Pdf, 10.065 kB), Prof. Zsuzsa Schaff

17:00- 17:20      EASL Hepatitis treatment strategies in the framework of elimination of viral hepatitis as a public health threat (Pdf, 2.220 kB), Mojca Maticic (Head Department Viral Hepatitis, University medical Centre Ljubljana, Slovenia)

17:20- 17:40      Question and discussion

19:45    Dinner

 

Thursday 31 October 2019

Session 6:  National hepatitis plan and the different stakeholders 

Chairs: Béla Hunyady – David Goldberg

08:30- 08:50      The Hungarian Hepatitis Committee. National program for chronic viral hepatitis elimination (Pdf, 246 kB), Prof. Béla Hunyady

08:50- 09:10      Financial aspects of HCV elimination. Is it „cost saving”? Cost of screening and treatment (Pdf, 342 kB), Dr. Aron Zoltán Vincziczki (NEAK)

09:10- 09:30      Best practices: National Hepatitis approach of Slovenia (Pdf, 3.210 kB), Mojca Maticic (Head Department Viral Hepatitis, University medical Centre Ljubljana, Slovenia)

09:30- 09:40      Question and discussion

09:40- 10:00      Prevention and control activities by Civil society and patient organisation (Pdf, 1.658 kB) VIMOR Hepatitis patient organisation / Hungarian Liver Patients Association, Antalné Nagy

10:00- 10:20      Question and discussion

10:20- 11:00      Coffee break

Session 7:  groups discussion - What are the needs to Eliminate viral hepatitis by 2030

Chairs: Mihály Makar – Daniel Lavanchy

11:00- 11:20      WHO Global Strategy and the European action plan for viral hepatitis elimination, including WHO/Europe good practices (Pfd, 1.966 kB), Antons Mozalevskis, (WHO Regional Office for Europe)

11:20 - 12:30     Groups or Panel  discussion:  Assess the needs to achieve the WHO’s Regional office for Europe- targets for elimination viral hepatitis in Hungary by 2030

Group 1 - Epidemiological surveillance, screening, monitoring and analysis of the effectiveness of prevention and treatment programs, informing the public

Group 2 - Prevention of viral hepatitis: improvement of vaccine prevention programs, prevention in high-risk groups, prevention in health care settings

Group 3 - Treatment of viral hepatitis: recommendations based on epidemiology and disease burden data, increasing access to treatment, coverage of the most affected groups

12:30-13:00       Presentation outcome of the groups sessions

13:00-14:30       Lunch

Session 8:  Conclusion of the meeting

Chairs: Zsuzsa Schaff – Daniel Shouval

14:30 – 15:30    Conclusion of the meeting + Final discussion (draft will be updated; Pdf, 170 kB), David FitzSimons

 

 

Tags: